ATRA vs HON · rev $128.9M vs P/E 36, rev $9.72B
Atara Biotherapeutics Inc (ATRA) versus Honeywell International Inc (HON) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal Kapur.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
ATRA currently screens at market cap $87.1M. HON currently screens at market cap $144.86B and trailing P/E 36.5.
Not investment advice. Open the ATRA and HON stock pages for the full models.
Not investment advice.